The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
In my opinion the value is in the hands of traders, for technical analysis at the moment.
At the moment when the communication will take place with official and detailed announcements on contracts, orders, US market, acquisition, merger, outlook, diversification, result of the dispute with DHSC then we can hope that there will be a change of trend.
(automatic translation translate)
Hello Dogwilson
I live in an old Norman farm that we have renovated for over thirty years.
I have a horseshoe to bring "good luck" that I put the curved part up until the day I saw a show in which he recommended positioning the round at the bottom.
Since the round is at the bottom but I haven't noticed any change in my life, just see the course of Novacyt.
Regards
(automatic translation translate)
Sorry I posted the wrong message!
Do you think the company is ready to repurchase shares, so with a loss of liquidity when they have issued the possibility of making an acquisition?
Hope you understand the machine translation !!
if there is an acquisition program, the cash will be all the more useful to them, in my opinion.
In addition, their research section must and should absorb a good part of it with current and future projects.
(traduction Translate)
Sorry
What is a liquidity contract?
When the floating capital of a company is low, and stock market transactions on its stock are rare, an offer to buy or sell may not find a buyer. This sometimes causes a strong variation (volatility) in stock prices. To avoid this pitfall, an authorized financial partner (bank, stockbroker) can offer, with the agreement of the listed company, sell or buy orders at a price estimated "fair", so as not to alter the trend of the stock market price. Such buy or sell orders may not exceed a quotation range of 3%. The narrower this range, the more "liquid" the title. The commitment of the listed company is concretized through a liquidity contract, signed with the financial partner. This agreement must be made public by press release.
Liquidity contract and accounting
Under a liquidity contract, the transactions of sale or purchase of shares are recorded in a specific account, a "liquidity account" solely dedicated to these operations. Shares in a liquidity contract are generally classified as fixed securities. However, they may be reclassified as investment securities, through an information note or a deliberation of the board of directors, if the liquidity contract is made for the sole purpose of regularizing the stock market price.
ADVERTISING
Liquidity contract and share buyback
Any listed company has the possibility to conclude a liquidity contract with a financial partner authorized for sale and purchase operations. The contract may be set up as part of a share buyback program, previously authorized by the company's general meeting or its board of directors. All operations are carried out during the trading session. Every six months, a press release from the company presents the balance sheet of the implementation of the contract, specifying the number of shares and cash resources available at the balance sheet date, and indicating the name of the service provider.
Liquidity contract and AMF
The liquidity contract is a widespread practice in France, subject to mandatory information from the Autorité des marchés financiers (AMF), which supervised the system in the early 2000s. We can even speak of French specificity, since about 400 of the 450 existing liquidity contracts in Europe in 2018 were initiated by French listed companies. Currently, the AMF's framework for liquidity contracts is undergoing regulatory changes, aimed at adapting it to the new European regulation on market abuse, negotiated with the European Securities and Markets Authority (ESMA). The AMF's work on this subject, finalized in 2021, will eventually lead to new limits on allocated resources, order prices and the volume of intervention during the day.
https://novacyt.com/wp-content/uploads/2021/09/Novacyt-Liquidity-Agreement-01-Se ptember-2021-ENGLISH.pdf
GDWK
Bonjour
Je pense que Novacyt n'a pas été retenue par le gouvernement Français car les tests devaient être trop chers.
Après peut-être que Novacyt ne s'est pas assez défendue car elle avait un gros marché avec le DHSC et d'autres pays.
Avait-elle les capacités pour fournir aussi la France.
Chez nous c'est Biosynex qui s'est bien défendu pour vendre ses produits.
Mais
Rien n'est perdu pour Novacyt à mon avis.
Les LFT peuvent être une opportunité pour trouver un marché en France, maintenant est-ce que Novacyt le veut vraiment, il ne faut pas oublier que nous attendons tous des nouvelles du marché US qui pourrait apporter beaucoup pour la société.
Comme vous, nous nous posons beaucoup de questions depuis tous ces mois passés sans réelle communication.
Il faut absolument pour que le cours change de tendance qu'on ait des News...
Bonne journée!
Désolé d'écrire en Français, je vois que ça en chagrine certains, mon Anglais d'école n'est pas assez bon.
Personnellement, je n'ai pas de problème pour vous lire car mon navigateur traduit automatiquement les textes Anglais en Français.
Bonne journée
Oui Covidopportuniste
Mais certains ont mal depuis les 8€, sans parler des 13€ (cours France).
Sinon tu peux demander à tes amis Anglais de renforcer pour être à la même quantité d'actions que les Français. ;-)
Bonjour
Je suis Français et sur le forum boursorama "cigale56" et sur le groupe Novacyt sur Facebook.
Oui c'est navrant ce cours, on va chercher de nouveaux supports.
Pour changer la tendance, il faut absolument des News.
Contrats, commandes, marché US, acquisition, fusion, perspectives, diversification, LFT, résultat litige DHSC...
Bonne journée!